Agilent PD-L1 assay receives FDA approval for use as a companion diagnostic
Assay will help guide treatment decisions in cases of non-small cell lung cancer
Assay will help guide treatment decisions in cases of non-small cell lung cancer
The Alinity m molecular laboratory COVID-19 test instrument claims it can run up to 1,080 tests in 24 hours
Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11
AMSBIO's new service utilizes their novel lentiviral system to aid the development of therapeutic drugs and vaccines
Preliminary results from a government-sponsored study suggest that drug used to treat Ebola may help COVID-19 patients
The serology test promises 100% sensitivity and can help assess patients' immune response to the virus
The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe
The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment
Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.
Collaboration will enable global development, manufacturing and distribution of the vaccine
These models aim to accelerate treatment development prior to clinical trials
The combination of the unique technologies aims to bring a novel angle to combat the global pandemic
Register for free today to discover the latest science and technology advancements in coronavirus research, CAR T-cell therapy, genomics, liquid biopsies, imaging, drug delivery mechanisms, microbiome research and more
Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease
The team at the University of Edinburgh believe new therapies could be discovered before a vaccine becomes available
The new product line includes the MutaPLEX RT-PCR assay and ELISA kits to detect IgM and IgG antibodies
The testing capability of Mologic's kits is expected to relieve immediate testing pressures in the UK and Africa
The only FDA-approved test that measures G6PD provides key insight to inform drug therapy options
The strategic partnership with Australian National Phenome Centre (ANPC) aims to support the work of their researchers
Vehicle manufacturer utilizes infrastructure to expand production to face masks and gowns for frontline medical staff
Recognition comes as the publisher launches a series of Virtual Summits to support the science industry through the COVID-19 crisis
Test runs on Bio-Rad’s QX200 and QXDx ddPCR systems and aims to provide early detection of COVID-19
Studies in China show that the QX200 ddPCR systems can detect low levels of infection in individuals
Oxford Cannabinoid Technologies has announced the pre-clinical development of a new cannabinoid compound ‘OCT461201’ to treat IBS